An amniotic membrane eye procedure places a thin sheet of human placental tissue onto a damaged or inflamed eye surface to promote healing. The membrane, harvested from donated placentas after cesarean deliveries, acts as a biological bandage that reduces inflammation, encourages new cell growth, and protects fragile corneal tissue while it repairs itself. The procedure has been used in ophthalmology for decades, but advances in tissue preservation and simpler placement methods have made it far more common in recent years, expanding its use from severe surgical cases to conditions as routine as moderate dry eye.
What the Amniotic Membrane Actually Is
The amniotic membrane is the innermost layer of the placenta, the part that lines the sac surrounding the fetus during pregnancy. It consists of a single layer of epithelial cells sitting on a thick basement membrane, and that basement membrane is what makes it so useful for eye repair. It provides a scaffold that damaged corneal and conjunctival cells can grow across, essentially giving the eye’s own healing machinery a surface to work on.1PubMed Central. Amniotic membrane transplantation: structural and biological properties, tissue preparation, application and clinical indications Beyond just physical support, the tissue is loaded with growth factors and signaling molecules that actively tamp down inflammation and coax the eye surface toward regeneration rather than scarring.
A major reason amniotic membrane works so well on eyes is that the tissue suppresses both arms of the immune system. Amniotic cells dial back the body’s innate inflammatory response and its adaptive immune response, which means the eye tolerates the graft without the aggressive rejection reactions that plague many other transplanted tissues.2PubMed Central. Immunomodulatory Properties of Amniotic Membrane Derivatives and Their Potential in Regenerative Medicine This immune-quieting property also helps calm the inflamed eye surface itself, which is often a big part of the problem the membrane is being used to solve.
How Grafts Are Preserved Before Use
Fresh amniotic membrane has the highest concentration of beneficial molecules, but it is impractical to keep on hand. So tissue banks process the membrane into forms that can be stored and shipped. The two main approaches, cryopreservation and dehydration, preserve different things.
Cryopreserved tissue is frozen at very low temperatures, which keeps the membrane’s three-dimensional structure largely intact along with key biological signals like high molecular weight hyaluronic acid and pentraxin 3. Dehydrated tissue, by contrast, tends to lose its native architecture and most of those crucial signaling molecules.3PubMed. Comparison of cryopreserved amniotic membrane and umbilical cord tissue with dehydrated amniotic membrane/chorion tissue That sounds like cryopreservation should always win, but the trade-off is convenience: dehydrated membrane can be stored at room temperature and is easier to stock in a clinic.
The picture is more nuanced when you look at specific growth factors. One study found that cryopreserved membrane retained only about 13% of total epidermal growth factor (EGF), losing over half in a single wash, while newer drying methods using sugar-based protectants like trehalose retained up to 88% of EGF.4PubMed Central. Augmented Dried versus Cryopreserved Amniotic Membrane as an Ocular Surface Dressing So neither preservation method is clearly superior across the board. The choice often depends on the clinical situation, what is available locally, and whether the surgeon prioritizes structural integrity or growth factor content.
How the Membrane Is Placed on the Eye
There are two fundamentally different ways to use amniotic membrane on the eye, and the distinction matters because they serve different purposes.
An “inlay” graft is placed directly into a wound bed after damaged tissue has been removed. The membrane becomes a permanent part of the eye’s surface, integrating into the corneal stroma over time as new cells grow across and anchor into it. When the wound is deep, surgeons may stack multiple layers of membrane to fill the defect. An “onlay” or “patch” graft, on the other hand, is draped over the surface epithelial side down and acts as a temporary biological bandage. It protects the healing surface from environmental insult and the eyelid’s blinking friction, then gradually dissolves or is removed once the eye has healed underneath.5PubMed Central. Amniotic Membrane Transplantation in Ophthalmology: An Updated Perspective
Traditionally, both types required sutures to hold the membrane in place, which meant an operating room, anesthesia, and a longer procedure. Sutureless methods have changed that. One approach uses a specially designed biocompatible ring that holds the membrane against the eye surface. In a small series, the ring technique took an average of three minutes and could be done in an office setting, producing good outcomes in patients with various ocular surface disorders.6PubMed. Sutureless fixation of amniotic membrane using a soft ring for ocular surface diseases Another common sutureless method sandwiches a dehydrated membrane under a bandage contact lens, which holds it against the cornea while it dissolves. These office-friendly techniques are a big reason amniotic membrane use has expanded so dramatically.
Conditions the Procedure Treats
The list of eye conditions treated with amniotic membrane is long, but a few stand out as the most common and best-studied uses.
Dry Eye Disease
Dry eye has become the single largest driver of amniotic membrane use. In the U.S. Medicare population, dry eye accounted for 44% of all sutureless amniotic membrane graft use by 2020, up from just 7% in 2011.7PubMed Central. Utilization Patterns and Costs of Ocular Amniotic Membrane Grafts in the Medicare Population For moderate to severe dry eye that has not responded to drops and other therapies, the membrane can reset the ocular surface. Studies of cryopreserved membrane for dry eye show improvements in both symptoms and the biological health of the cornea, including nerve regeneration.8PubMed Central. Amniotic membrane transplantation for managing dry eye and neurotrophic keratitis
One trial using dehydrated membrane held in place by a specialized bandage contact lens found a 65% reduction in dry eye symptom scores at six months, with 88% of participants showing improvement within the first month. The membrane also reduced corneal inflammation markers and improved corneal nerve measurements.9PubMed Central. Sutureless Dehydrated Amniotic Membrane (Omnigen) Application Using a Specialised Bandage Contact Lens (OmniLenz) for the Treatment of Dry Eye Disease: A 6-Month Randomised Control Trial The nerve regeneration piece is interesting because dry eye often involves damaged corneal nerves, and restoring those nerves may address the underlying problem rather than just masking symptoms.
Persistent Corneal Epithelial Defects
When the cornea’s surface layer refuses to heal despite standard treatment, a persistent epithelial defect can threaten vision. These stubborn wounds may stem from nerve damage, infections, or previous surgeries. A large case series using amniotic membrane-derived dry matrix for these defects found that 58% of eyes achieved complete healing and another 28% showed partial healing, with an average treatment period of about three weeks. Vision stayed stable or improved in the vast majority of patients.10PubMed Central. Management of Persistent Corneal Epithelial Defects with Human Amniotic Membrane-derived Dry Matrix These results held across a range of underlying causes, from limbal stem cell deficiency to microbial infections to failed corneal transplants.
Chemical and Thermal Burns
Chemical burns to the eye are emergencies, and amniotic membrane has been used as an early intervention to limit damage. In a prospective study of 15 eyes with acute chemical burns, all patients had immediate pain relief after the membrane was placed. About 60% of eyes achieved surface healing within one to four weeks, and two-thirds showed improved vision over the follow-up period.11PubMed. Amniotic membrane transplantation in acute chemical burns For mild to moderate burns, the membrane alone can restore the corneal and conjunctival surfaces and prevent scarring. For severe burns, it helps reconstruct the conjunctiva and reduce inflammation but cannot prevent loss of the limbal stem cells that the cornea needs for long-term surface renewal; those patients typically need additional stem cell transplantation.12PubMed. Amniotic membrane transplantation for acute chemical or thermal burns
It is worth noting that a Cochrane systematic review found the randomized controlled trial evidence for amniotic membrane in acute burns is thin. Mild burns tend to heal well on their own, and for the most severe burns, the membrane has not been shown to prevent the worst outcomes.13PubMed Central. Amniotic membrane transplantation for acute ocular burns That doesn’t mean the procedure is useless in burns, but it does mean the strongest case for it lies in the moderate-severity range, where the evidence is more encouraging.
Pterygium Surgery
A pterygium is a fleshy growth that creeps from the white of the eye onto the cornea. Surgical removal is common, but the growth tends to come back. Amniotic membrane can be grafted into the bare area after removal to reduce recurrence. In one large series combining membrane grafting with brief intraoperative use of mitomycin C, the overall recurrence rate was under 6%.14PubMed Central. Amniotic Membrane Grafts to Reduce Pterygium Recurrence The membrane fills the gap where tissue was removed and discourages the aggressive regrowth that makes pterygium surgery frustrating for patients and surgeons alike.15PubMed Central. Amniotic membrane transplantation for primary pterygium surgery
Neurotrophic Keratitis and Corneal Nerve Damage
Neurotrophic keratitis is a degenerative condition where corneal nerves are damaged, leaving the cornea unable to sense irritation or trigger its own healing reflexes. Amniotic membrane appears to encourage nerve regrowth, not just surface healing. One study tracked corneal nerve density in dry eye patients treated with self-retained cryopreserved membrane and found a significant increase from baseline to three months, accompanied by improved corneal sensitivity.16PubMed Central. Corneal Nerve Regeneration after Self-Retained Cryopreserved Amniotic Membrane in Dry Eye Disease A systematic review confirmed that in cases of neurotrophic keratitis and deep stromal ulcers, amniotic membrane transplantation outperformed standard bandage contact lenses in healing outcomes, particularly when the membrane was left in place for longer periods.17PubMed Central. The Role of Bandage Contact Lenses Versus Amniotic Membrane in Corneal Wound Healing: A Systematic Review
When the Graft Fails
Amniotic membrane grafts do not always work. In neurotrophic keratitis specifically, one study found that epithelial defects recurred in 70% of patients, a strikingly high number. The strongest predictor of failure was being on systemic immunosuppressive therapy, which increased the odds of recurrence nearly twentyfold. The number of prior amniotic membrane grafts a patient had received also predicted failure, with each additional graft raising the odds of recurrence. Researchers identified a high-risk cluster of patients characterized by immunosuppression, multiple prior grafts, previous eye surgery, and inflammatory complications, with a 72% recurrence rate.18PubMed Central. Machine Learning Identifies Predictors of Amniotic Membrane Graft Failure in Neurotrophic Keratitis
This matters because amniotic membrane is sometimes presented as a straightforward fix. For many patients it is. But for those with compromised immune systems, underlying inflammatory disease, or eyes that have already been through multiple surgeries, the odds tilt significantly. The procedure is low-risk in terms of complications, but graft failure just means the underlying problem hasn’t been solved and will need another approach.
The Cost Question
The rapid expansion of amniotic membrane use, especially for dry eye, has raised questions about cost. Charges for ocular sutureless amniotic membrane grafts in the Medicare system grew from $3.5 million in 2011 to $95.6 million in 2020. Charges specifically for dry eye treatment jumped from $250,000 to $41.4 million over the same period. The spending is also concentrated: about 28% of all amniotic membrane claims came from just 1% of providers, and patients were more likely to receive a graft when seen by an optometrist than other eye care providers.7PubMed Central. Utilization Patterns and Costs of Ocular Amniotic Membrane Grafts in the Medicare Population
Those numbers invite scrutiny. A cost-utility analysis comparing cryopreserved amniotic membrane to topical cyclosporine (a common prescription dry eye drop) for moderate to severe dry eye found that when you factor in both direct medical costs and indirect costs like lost productivity, amniotic membrane was actually the less expensive option over a year and provided slightly better quality-of-life outcomes. A simulation showed it was the less costly, more effective option about 92% of the time. However, if you look at direct medical costs alone, cyclosporine drops were cheaper: roughly $4,100 versus $10,300 for the membrane procedure.19PubMed Central. Cost utility analysis of cryopreserved amniotic membrane versus topical cyclosporine for the treatment of moderate to severe dry eye syndrome So whether the procedure is “worth it” depends heavily on which costs you count. For someone with severe dry eye that keeps them from working, the membrane may pay for itself. For someone with mild symptoms, escalating to a tissue graft is harder to justify on cost grounds.
Provider Concentration and Overuse Concerns
The finding that 1% of providers submitted 28% of amniotic membrane claims has not gone unnoticed in ophthalmology. Part of this likely reflects legitimate specialization: certain clinics focus on ocular surface disease and naturally see more candidates. But it also raises the possibility that some providers are using the graft more aggressively than the evidence supports, particularly for milder dry eye where the benefits over cheaper treatments are less clear. Patients who are offered an amniotic membrane procedure for dry eye may want to ask whether they have tried and failed standard therapies first, what specific outcome improvement the provider expects, and how many grafts the provider performs annually. These are reasonable questions for any procedure that has gone from niche to mainstream in under a decade.
Amniotic Membrane Extract Eye Drops
A newer frontier skips the membrane entirely and delivers its beneficial molecules as liquid eye drops. Researchers have developed amniotic membrane extract (AME) drops by processing the tissue and capturing its growth factors and anti-inflammatory compounds in solution.20PubMed Central. Amniotic membrane extract and eye drops: a review of literature and clinical application The idea is appealing because drops are far easier to apply than a tissue graft and could be used at home.
In an experimental alkaline burn model, AME drops applied topically at a clinically relevant dose outperformed actual amniotic membrane transplantation on several measures. The drops produced significantly less corneal opacity, less stromal inflammation, less scarring, and less abnormal blood vessel growth compared to both the transplant group and untreated controls.21PubMed. Topical application of amniotic membrane extract at a clinically correlated dose is effective in limiting complications in an experimental ocular alkaline burn model Those results are from an animal model, so they cannot be directly applied to human patients yet. But the concept of delivering the membrane’s healing properties without the membrane itself could eventually simplify treatment for many eye conditions, particularly in settings where tissue banking infrastructure is limited or where repeated in-office graft placement is impractical.
What the Procedure Feels Like as a Patient
If you are scheduled for a sutureless amniotic membrane placement, the experience is considerably less dramatic than “eye surgery” might suggest. The membrane is typically placed in a clinic exam room, not an operating room. Your eye is numbed with topical anesthetic drops. The membrane, whether held by a ring device or tucked under a bandage contact lens, is positioned over the cornea in a matter of minutes. You go home the same day, usually wearing the bandage contact lens for several days while the membrane dissolves underneath. Most patients report mild discomfort comparable to wearing a contact lens, and the membrane itself is translucent enough that vision is blurry but not completely obscured during the healing period.
Sutured grafts for more serious conditions like deep ulcers or post-burn reconstruction are a different experience. These are performed in an operating room under local or occasionally general anesthesia, and recovery involves more significant discomfort, patching, and follow-up visits. The healing timeline is longer, and the stakes are higher because these patients typically have more severe underlying eye disease.
Regardless of the method, most patients need at least one follow-up visit within the first week. The provider checks that the membrane is staying in position, monitors for infection, and assesses early signs of healing. For sutureless dry eye applications, many patients notice symptom improvement within the first month, though the full effect on corneal nerves and inflammation may take three to six months to manifest.